Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2456834rdf:typepubmed:Citationlld:pubmed
pubmed-article:2456834lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:2456834lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:2456834lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:2456834lifeskim:mentionsumls-concept:C0007776lld:lifeskim
pubmed-article:2456834lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:2456834lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:2456834lifeskim:mentionsumls-concept:C1621967lld:lifeskim
pubmed-article:2456834lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:2456834lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:2456834lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:2456834pubmed:issue1-2lld:pubmed
pubmed-article:2456834pubmed:dateCreated1988-9-15lld:pubmed
pubmed-article:2456834pubmed:abstractTextThe autoradiographic distribution of the 3 neurokinin (NK) receptor sub-types, NK-1, NK-2 and NK-3, was compared in rat cerebral cortex during post-natal development using [125I]Bolton-Hunter-substance P, (2-[125I]iodohistidyl1)neurokinin A and [125I]Bolton-Hunter-eledoisin as respective radioligands. Throughout brain development, NK-1 receptor sites are present in low densities with some enrichment seen in lamina III while NK-3 binding sites are concentrated in layers IV and V. However, it appears that NK-2 receptors are mostly expressed in lamina VI and only during the first two postnatal weeks. These results demonstrate further the existence and differential ontogeny of 3 classes of NK receptors in rat brain cortex.lld:pubmed
pubmed-article:2456834pubmed:languageenglld:pubmed
pubmed-article:2456834pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2456834pubmed:citationSubsetIMlld:pubmed
pubmed-article:2456834pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2456834pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2456834pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2456834pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2456834pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2456834pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2456834pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2456834pubmed:statusMEDLINElld:pubmed
pubmed-article:2456834pubmed:monthJunlld:pubmed
pubmed-article:2456834pubmed:issn0006-8993lld:pubmed
pubmed-article:2456834pubmed:authorpubmed-author:EscherEElld:pubmed
pubmed-article:2456834pubmed:authorpubmed-author:QuirionRRlld:pubmed
pubmed-article:2456834pubmed:authorpubmed-author:DamT VTVlld:pubmed
pubmed-article:2456834pubmed:issnTypePrintlld:pubmed
pubmed-article:2456834pubmed:day21lld:pubmed
pubmed-article:2456834pubmed:volume453lld:pubmed
pubmed-article:2456834pubmed:ownerNLMlld:pubmed
pubmed-article:2456834pubmed:authorsCompleteYlld:pubmed
pubmed-article:2456834pubmed:pagination372-6lld:pubmed
pubmed-article:2456834pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2456834pubmed:meshHeadingpubmed-meshheading:2456834-...lld:pubmed
pubmed-article:2456834pubmed:meshHeadingpubmed-meshheading:2456834-...lld:pubmed
pubmed-article:2456834pubmed:meshHeadingpubmed-meshheading:2456834-...lld:pubmed
pubmed-article:2456834pubmed:meshHeadingpubmed-meshheading:2456834-...lld:pubmed
pubmed-article:2456834pubmed:meshHeadingpubmed-meshheading:2456834-...lld:pubmed
pubmed-article:2456834pubmed:meshHeadingpubmed-meshheading:2456834-...lld:pubmed
pubmed-article:2456834pubmed:meshHeadingpubmed-meshheading:2456834-...lld:pubmed
pubmed-article:2456834pubmed:meshHeadingpubmed-meshheading:2456834-...lld:pubmed
pubmed-article:2456834pubmed:meshHeadingpubmed-meshheading:2456834-...lld:pubmed
pubmed-article:2456834pubmed:meshHeadingpubmed-meshheading:2456834-...lld:pubmed
pubmed-article:2456834pubmed:meshHeadingpubmed-meshheading:2456834-...lld:pubmed
pubmed-article:2456834pubmed:meshHeadingpubmed-meshheading:2456834-...lld:pubmed
pubmed-article:2456834pubmed:meshHeadingpubmed-meshheading:2456834-...lld:pubmed
pubmed-article:2456834pubmed:year1988lld:pubmed
pubmed-article:2456834pubmed:articleTitleEvidence for the existence of three classes of neurokinin receptors in brain. Differential ontogeny of neurokinin-1, neurokinin-2 and neurokinin-3 binding sites in rat cerebral cortex.lld:pubmed
pubmed-article:2456834pubmed:affiliationDouglas Hospital Research Centre, Verdun, Qué, Canada.lld:pubmed
pubmed-article:2456834pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2456834pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2456834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2456834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2456834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2456834lld:pubmed